An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients

NCT05356858 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
6
Enrollment
OTHER
Sponsor class

Stopped Difficult in participant recruiting

Conditions

Interventions

Sponsor

Xuanwu Hospital, Beijing